26 studies found for: Open Studies | "Herpes Simplex"
|1||Not yet recruiting||
Herpes Simplex Reactivation in Adult Critical Care Patients
The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis
Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
|4||Not yet recruiting||
A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?
30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Antiviral Prophylaxis in a Burn Population
Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?
Improving Blood Safety and HIV Testing in Brazil
Interferon Responses in Eczema Herpeticum (ADEH)
|13||Not yet recruiting||
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers
A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer
A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis
Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis
TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase (HSV-Tk) Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
† Indicates status has not been verified in more than two years